Recent Material Events - Eli Lilly And Company (LLY)

Filing Date	Description
2008-10-06	On October 6, 2008, Eli Lilly and Company (the “Company”) issued a press release announcing that it has entered into an Agreement and Plan of Merger among ImClone Systems Incorporated (“ImClone 48;), the Company and Alaska Acquisitio ...
2008-07-24	On July 24, 2008, we issued a press release announcing our results of operations for the quarter ended June 30, 2008, including, among other things, an income statement and balance sheet for those periods. In addition, on the same day we are holding ...
2008-04-25	On April 21, 2008, the shareholders approved amendments to the company’s 2002 Lilly Stock Plan (the “Plan”). Under the Plan, all employees of the company are eligible to participate. The Compensation Committee of the board (the “C ...
2008-03-13	On March 7, 2008, Eli Lilly and Company announced the termination of development of its AIR® Insulin program, which was being conducted in partnership with Alkermes, Inc. The program has been in phase III clinical development as a potential trea ...
2008-01-29	On January 29, 2008, we issued a press release announcing our results of operations for the quarter and fiscal year ended December 31, 2007, including, among other things, an income statement for those periods. In addition, on the same day we held a ...
2007-12-19	On December 17, 2007, Sidney Taurel, chairman of the board and chief executive officer of the company, announced his retirement as chief executive officer as of March 31, 2008, and as chairman and a member of the board of directors as of December 31, ...
2007-10-19	On October 18, 2007, we issued a press release announcing our results of operations for the quarter and nine month period ended September 30, 2007, including, among other things, an income statement for those periods. In addition, on the same day we ...
2007-03-14	On March 7, 2007, Eli Lilly and Company (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”), between the Company and, as representatives of the several underwriters named therein, Credit Suisse Se... ...
2007-03-05	Eli Lilly and Company today announced that it has signed a definitive merger agreement whereby Lilly will acquire Hypnion, Inc., a privately held neuroscience drug discovery company focused on sleep disorders. The transaction has received the requisi... ...
2007-01-31	On January 29, 2007, Eli Lilly and Company (the “company” or “we” or “us”) completed its acquisition of ICOS Corporation. As a result of closing the transaction, the company has acquired all of the outstanding shares of... ...